SHELTON CAPITAL MANAGEMENT - PLURISTEM THERAPEUTICS INC ownership

PLURISTEM THERAPEUTICS INC's ticker is PSTI and the CUSIP is 72940R300. A total of 57 filers reported holding PLURISTEM THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 2.65 and the average weighting 0.0%.

Quarter-by-quarter ownership
SHELTON CAPITAL MANAGEMENT ownership history of PLURISTEM THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$158,000
-40.6%
128,5320.0%0.01%
-30.0%
Q1 2022$266,000
-24.0%
128,532
-46.4%
0.01%
-16.7%
Q4 2021$350,000
-45.0%
240,0000.0%0.01%
-52.0%
Q3 2021$636,000
-27.0%
240,000
+9.1%
0.02%
-24.2%
Q2 2021$871,000
-17.0%
220,0000.0%0.03%
-10.8%
Q1 2021$1,049,000220,0000.04%
Other shareholders
PLURISTEM THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
NIA IMPACT ADVISORS, LLC 732,135$1,940,0000.83%
Green Alpha Advisors, LLC 61,759$164,0000.11%
Values First Advisors, Inc. 49,179$130,0000.08%
GSA CAPITAL PARTNERS LLP 257,684$683,0000.07%
SHELTON CAPITAL MANAGEMENT 240,000$636,0000.02%
Walleye Capital LLC 154,997$411,0000.01%
PDT Partners, LLC 59,400$157,0000.01%
Archford Capital Strategies, LLC 13,091$35,0000.01%
Susquehanna International Group Ltd. 13,164$35,0000.01%
MEITAV INVESTMENT HOUSE LTD 167,593$444,0000.01%
View complete list of PLURISTEM THERAPEUTICS INC shareholders